|
GB1022214A
(en)
|
1963-01-31 |
1966-03-09 |
Sterling Drug Inc |
Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation
|
|
IL51092A0
(en)
|
1976-12-10 |
1977-02-28 |
Abic Ltd |
Naphthyridine derivatives and their preparation
|
|
JPS57176958A
(en)
|
1981-04-24 |
1982-10-30 |
Nissan Chem Ind Ltd |
1-(2',6'-dichlorophenyl)-2-methylthioindole and its preparation
|
|
JPS57176956A
(en)
|
1981-04-24 |
1982-10-30 |
Nissan Chem Ind Ltd |
Preparation of 1-(2',6'-dichlorophenyl)-2-indolinone
|
|
JPS57176957A
(en)
|
1981-04-24 |
1982-10-30 |
Nissan Chem Ind Ltd |
Preparation of 1-(2',6'-dichlorophenyl)-2-indolinone
|
|
JPS57176959A
(en)
|
1981-04-24 |
1982-10-30 |
Nissan Chem Ind Ltd |
1-(2',6'-dichlorophenyl)-2,3bis(methylthio) indole and its preparation
|
|
US4617307A
(en)
|
1984-06-20 |
1986-10-14 |
Ciba-Geigy Corporation |
Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
|
|
US4889861A
(en)
|
1982-12-21 |
1989-12-26 |
Ciba-Geigy Corp. |
Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors
|
|
FI77669C
(fi)
|
1983-04-13 |
1989-04-10 |
Ciba Geigy Ag |
20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
|
|
US4698341A
(en)
|
1983-07-30 |
1987-10-06 |
Godecke Aktiengesellschaft |
Use of 1,6-naphthyridinone derivatives in treating pulmonary thrombosis
|
|
US4767762A
(en)
*
|
1985-12-23 |
1988-08-30 |
Abbott Laboratories |
Tricyclic quinoline and naphthyride antibacterials
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
IL101860A0
(en)
|
1991-05-31 |
1992-12-30 |
Ici Plc |
Heterocyclic derivatives
|
|
WO1993011782A1
(en)
|
1991-12-19 |
1993-06-24 |
Southwest Foundation For Biomedical Research |
Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
|
|
IL111785A0
(en)
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
EP0787720B1
(en)
|
1994-10-20 |
2003-07-16 |
Wakunaga Seiyaku Kabushiki Kaisha |
Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient
|
|
PT897919E
(pt)
|
1996-04-19 |
2004-11-30 |
Wakunaga Pharma Co Ltd |
Novos derivados do acido piridonacarboxilico ou seus sais e agentes anti-bacterianos contendo-os como ingrediente activo
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US6136823A
(en)
|
1996-11-28 |
2000-10-24 |
Wakunaga Pharmaceutical Co., Ltd. |
Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
|
|
JP2002517486A
(ja)
|
1998-06-12 |
2002-06-18 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
AU5509099A
(en)
|
1998-08-03 |
2000-02-28 |
Basf Corporation |
Pyridinones for the treatment of sexual dysfunction
|
|
GT199900147A
(es)
|
1998-09-17 |
1999-09-06 |
|
1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
|
|
US6197786B1
(en)
|
1998-09-17 |
2001-03-06 |
Pfizer Inc |
4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
US6683113B2
(en)
|
1999-09-23 |
2004-01-27 |
Pharmacia Corporation |
(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
|
|
HUP0301335A3
(en)
|
2000-04-12 |
2006-02-28 |
Novartis Ag |
Combination of organic compounds
|
|
JP2003040866A
(ja)
|
2001-07-31 |
2003-02-13 |
Nippon Kayaku Co Ltd |
Ｎ置換インドール誘導体、その製造法及びそれを有効成分とする害虫防除剤
|
|
CN1578781A
(zh)
*
|
2001-09-26 |
2005-02-09 |
拜尔药品公司 |
用作抗糖尿病药物的1,8－萘啶衍生物
|
|
AU2003209388A1
(en)
|
2002-01-29 |
2003-09-02 |
Merck And Co., Inc. |
Substituted imidazoles as cannabinoid receptor modulators
|
|
JP2005529160A
(ja)
|
2002-05-31 |
2005-09-29 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
糖尿病及び糖尿病−関連障害の処置のための化合物及び組成物
|
|
DK1537114T3
(da)
|
2002-08-07 |
2006-11-13 |
Novartis Ag |
Organiske forbindelser som midler til behandling af aldosteronmedierede tilstande
|
|
CN100447142C
(zh)
|
2002-11-18 |
2008-12-31 |
诺瓦提斯公司 |
咪唑并[1,5a]吡啶衍生物及治疗醛固酮所介导疾病的方法
|
|
WO2005026164A1
(en)
|
2003-09-18 |
2005-03-24 |
Altana Pharma Ag |
Pharmacologically active imidazo[4,5-c]pyridines
|
|
JP4719681B2
(ja)
|
2003-09-23 |
2011-07-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
キナゾリンカリウムチャネル阻害剤
|
|
JP2007530550A
(ja)
|
2004-03-26 |
2007-11-01 |
イーライ リリー アンド カンパニー |
異脂肪血症を治療するための化合物および方法
|
|
UA90269C2
(ru)
|
2004-04-02 |
2010-04-26 |
Мицубиси Танабе Фарма Корпорейшн |
Тетрагидрохинолиновые производные и способ их получения
|
|
DE102004018198A1
(de)
|
2004-04-15 |
2005-11-03 |
Merck Patent Gmbh |
Sulfonamide
|
|
US7612088B2
(en)
|
2004-05-28 |
2009-11-03 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
JP5179174B2
(ja)
|
2004-05-28 |
2013-04-10 |
ノバルティス ファーマ アーゲー |
アルドステロンシンターゼ阻害剤としてのテトラヒドロ−イミダゾ［１，５−ａ］ピリジン誘導体
|
|
CA2568164A1
(en)
|
2004-05-28 |
2005-12-15 |
Speedel Experimenta Ag |
Heterocyclic compounds and their use as aldosterone synthase inhibitors
|
|
LT2502911T
(lt)
|
2004-06-24 |
2017-09-11 |
Vertex Pharmaceuticals Incorporated |
Atp surišančios kasetės transporterių moduliatoriai
|
|
WO2006005726A2
(en)
|
2004-07-09 |
2006-01-19 |
Speedel Experimenta Ag |
Heterocyclic compounds
|
|
DE102004054215A1
(de)
|
2004-11-10 |
2006-05-11 |
Merck Patent Gmbh |
Pyridopyrimidinonderivate
|
|
TW200716636A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
TW200716105A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Imidazole compounds
|
|
TW200716634A
(en)
|
2005-05-31 |
2007-05-01 |
Speedel Experimenta Ag |
Heterocyclic spiro-compounds
|
|
BRPI0612287A8
(pt)
|
2005-06-27 |
2019-01-22 |
Exelixis Inc |
composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
|
|
GT200600381A
(es)
|
2005-08-25 |
2007-03-28 |
|
Compuestos organicos
|
|
EP1783114A1
(en)
|
2005-11-03 |
2007-05-09 |
Novartis AG |
N-(hetero)aryl indole derivatives as pesticides
|
|
JP5460054B2
(ja)
|
2005-11-23 |
2014-04-02 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
腫瘍形成性ｒａｓ特異的細胞障害性化合物およびその使用法
|
|
TW200804378A
(en)
|
2005-12-09 |
2008-01-16 |
Speedel Experimenta Ag |
Organic compounds
|
|
US20090156875A1
(en)
|
2006-04-04 |
2009-06-18 |
Takafumi Tomioka |
Methane separation method, methane separation apparatus, and methane utilization system
|
|
TW200808812A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
TW200808813A
(en)
|
2006-04-12 |
2008-02-16 |
Speedel Experimenta Ag |
Imidazo compounds
|
|
EP1886695A1
(en)
|
2006-06-27 |
2008-02-13 |
Speedel Experimenta AG |
Pharmaceutical combination of an aldosterone synthase inhibitor and a glucocorticoid receptor antagonist or a cortisol synthesis inhibitor or a corticotropin releasing factor antagonist
|
|
CA2660701A1
(en)
|
2006-08-25 |
2008-03-06 |
Novartis Ag |
Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase
|
|
EP2094669A2
(en)
|
2006-12-18 |
2009-09-02 |
Novartis AG |
1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
|
|
KR20090090395A
(ko)
|
2006-12-18 |
2009-08-25 |
노파르티스 아게 |
4-이미다졸릴-1,2,3,4-테트라히드로퀴놀린 유도체 및 알도스테론/11-베타-히드록실라제 억제제로서의 그의 용도
|
|
EA200900811A1
(ru)
|
2006-12-18 |
2009-12-30 |
Новартис Аг |
Имидазолы в качестве ингибиторов альдостеронсинтазы
|
|
RU2009139811A
(ru)
|
2007-03-29 |
2011-05-10 |
Новартис АГ (CH) |
Гетероциклические спиросоединения
|
|
ES2494366T3
(es)
*
|
2008-02-22 |
2014-09-15 |
Otsuka Pharmaceutical Co., Ltd. |
Compuesto de benzodiacepina y composición farmacéutica
|
|
WO2010012745A2
(en)
|
2008-07-29 |
2010-02-04 |
Boehringer Ingelheim International Gmbh |
Benzimidazoles
|
|
AU2010283632B2
(en)
|
2009-08-10 |
2016-08-25 |
Ucl Business Plc |
Reversible covalent linkage of functional molecules
|
|
GB0917571D0
(en)
|
2009-10-07 |
2009-11-25 |
Karobio Ab |
Novel estrogen receptor ligands
|
|
KR20130059400A
(ko)
|
2010-08-25 |
2013-06-05 |
(주)네오팜 |
신규한 헤테로고리 화합물 및 이를 이용한 염증성 질환 치료용 조성물
|
|
EP2524915A1
(en)
|
2011-05-20 |
2012-11-21 |
Sanofi |
2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
|
|
ES2561298T3
(es)
|
2011-07-12 |
2016-02-25 |
F. Hoffmann-La Roche Ag |
Compuestos de aminometilquinolona
|
|
HK1201455A1
(en)
|
2012-01-27 |
2015-09-04 |
Gilead Sciences Inc |
Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
|
|
EP2855472B1
(en)
|
2012-04-05 |
2016-09-14 |
Boehringer Ingelheim International GmbH |
Naphthyridinone derivatives as inhibitors of cytomegalovirus dna polymerase
|
|
US9067894B1
(en)
|
2013-03-07 |
2015-06-30 |
Vanderbilt University |
Compound, composition, and method of activating GIRK potassium channel and use of same for treating conditions of interest
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2014152317A2
(en)
|
2013-03-15 |
2014-09-25 |
Melinta Therapeutics, Inc. |
Methods of treating gonorrhea infections using quinolone antibiotics
|
|
AR096022A1
(es)
|
2013-04-11 |
2015-12-02 |
Basf Se |
Compuestos de pirimidinio sustituido, útiles para combatir plagas de animales
|
|
WO2015019347A1
(en)
|
2013-08-08 |
2015-02-12 |
Yeda Research And Development Company Ltd. |
Girk as a therapeutic target of immune disorders and a marker of b cell subtypes
|
|
US20160326165A1
(en)
|
2013-12-26 |
2016-11-10 |
Kinki University |
Alkoxycarbonyl hemiacetal-type ester prodrug of pyridone carboxylic acid antibacterial drug
|
|
CN106573006A
(zh)
|
2014-08-21 |
2017-04-19 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为药物的rip1激酶抑制剂杂环酰胺
|
|
PE20180252A1
(es)
*
|
2015-06-09 |
2018-02-02 |
Bayer Pharma AG |
Moduladores alostericos positivos del receptor muscarinico m2
|
|
JOP20190086A1
(ar)
|
2016-10-21 |
2019-04-18 |
Novartis Ag |
مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
|